# FDA Advisory Committee’s Vote May Open A Drug-Compounding Back Door For Unapproved Peptides - healthaffairs.org

*Источник: healthaffairs.org*
*Дата: 2026-08-04*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNanVwdXpzR1p3bUNLdTRWUGstUHItV3NBb2VTa3pLR2tVc0NKZ18zNHZ6cHRoOTZIVDRhcFFfaWxWWGdFRk9qanh5WEhwS0tKeVZpQVNGeWh2V3ZtTExTeUpQaDh1X0lZNXZUZHNsOUJ1bW9UTTJ4MnBSYXJSNUhpaVJEMC0tQVlDN3A3Z2RmQzJabjRqUzZUYUVLSC1jSUVDV2FHdldQdzZjWWlhUzFlMEV4UW96SzEtRnlmZm5SeUVtZHhPa3BaVVkzUTNuQQ?oc=5" target="_blank">FDA Advisory Committee’s Vote May Open A Drug-Compounding Back Door For Unapproved Peptides</a>&nbsp;&nbsp;<font color="#6f6f6f">healthaffairs.org</font>

[Оригинал](https://www.healthaffairs.org/content/forefront/fda-advisory-committee-s-vote-may-open-drug-compounding-back-door-unapproved-peptides)